3 completed, 2 unknown. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Unknown 2 |
| Phase 1 | 3 | Completed 3 |
Follow Scleritis: new trials by email Literature Review of Scleritis trials Research Report on Scleritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tofacitinib for Inflammatory Eye Disease tofacitinib - Uveitis, Scleritis | Phase 2 | Unknown | Washington University School of Medicine | 5 | 2019-04-04 | 2021-02-01 |
| A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis ACTH (adrenocorticotropic hormone) gel - Scleritis | Phase 2 | Unknown | Metropolitan Eye Research & Surgery Institute | 30 | 2019-01-01 | 2023-10-23 |
| Gevokizumab for Active Scleritis Gevokizumab - Scleritis | Phase 1 / Phase 2 | Completed | National Eye Institute (NEI) | 8 | 2013-03-01 | 2018-07-06 |
| Sirolimus Injections for Autoimmune Scleritis Sirolimus - Scleritis | Phase 1 / Phase 2 | Completed | National Eye Institute (NEI) | 5 | 2012-01-01 | 2020-06-19 |
| Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation Rituximab - Scleritis, Orbital Disease | Phase 1 / Phase 2 | Completed | Oregon Health and Science University | 20 | 2007-01-01 | 2013-08-16 |
Orbital Diseases (1) · Uveitis (1)
Eye Diseases (5) · Scleral Diseases (5) · Uveal Diseases (1)
5-(tetradecyloxy)-2-furancarboxylic acid (1) · Adrenocorticotropic Hormone (1) · Gels (1) · Rituximab (1) · Sirolimus (1) · tofacitinib (1)
National Eye Institute (NEI) (2) · Metropolitan Eye Research & Surgery Institute (1) · Oregon Health and Science University (1) · Washington University School of Medicine (1)
United States (5)
Hatice N Sen, M.D. (2) · David K Scales, MD (1) · David S. Chu, MD (1) · Eric B Suhler, MD (1) · James T Rosenbaum, MD (1) · Lynn M Hassman, MD PhD (1) · Quan D Nguyen, MD, MSc (1)